Healthcare · coverage Feb 6, 2024–Sep 18, 2026
Estimated market comparison · not an official filing fact
Available with Pro
Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.
Disclosure alert preview
Based on a real public filing
Pete Sessions
$15K - $50K
This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Sep 25, 2026.
Official filingThis page summarizes public STOCK Act disclosures involving ABBV. It is useful for seeing which lawmakers reported ABBV transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Sep 18, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
Congressional Trader tracks 40 public STOCK Act disclosures for ABBVacross 17 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent ABBV filing shown here was filed on Sep 18, 2026 by Pete Sessions as a sale. Related lawmakers include Josh Gottheimer, Lisa C. McClain, Julia Letlow, Marjorie Taylor Greene, Jared Moskowitz.
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansRecent ABBV disclosures include Josh Gottheimer, Lisa C. McClain, Julia Letlow, Marjorie Taylor Greene, Jared Moskowitz.
The visible sample currently shows 25 purchases and 15 sales or partial sales.
No. This page summarizes public filings for research and monitoring. It is not investment advice.
